Coronavirus • 09 April, 2020

Kazakh scientists on coronavirus vaccine

2 timeviewed

Research Institute for Biological Safety Problems and National centre for biotechnology are developing a vaccine from coronavirus infection,  General Director of Research Institute for Biological Safety Problems says.

54 vaccines are currently being developed by states, of which two have entered the clinical trial stage the WHO says.

In total, 4 vaccines are planned to develop, 2 of which are vector-based and 2 are subunit-based based on fragments of the virus S-protein.

After preclinical and clinical trials, the most effective and safe of them will be selected.

Scientists are working in laboratories of the 3rd level of BSL-3 biosecurity on real strains of SARS-CoV-2 coronavirus.

The Institute has an agreement with the World Health Organization to develop vaccines against particularly dangerous infections for public health.

Last news

Non-oil deficit to be gradually reduced

Kazakhstan • 14 May, 2020

Expired documents valid until July 10

Society • 14 May, 2020

Kazakhstan to open mosques from May 18

Kazakhstan • 14 May, 2020

Restrictive measures to be lifted in stages

Coronavirus • 12 May, 2020

30 people died from COVID-19 in Kazakhstan

Coronavirus • 06 May, 2020

Flood in Turkestan region in photos

Region • 06 May, 2020

All flood victims to be compensated

Region • 06 May, 2020

Similar news